1. Home
  2. RGEN vs CELH Comparison

RGEN vs CELH Comparison

Compare RGEN & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • CELH
  • Stock Information
  • Founded
  • RGEN 1981
  • CELH 2004
  • Country
  • RGEN United States
  • CELH United States
  • Employees
  • RGEN 1783
  • CELH N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • CELH Beverages (Production/Distribution)
  • Sector
  • RGEN Health Care
  • CELH Consumer Staples
  • Exchange
  • RGEN Nasdaq
  • CELH Nasdaq
  • Market Cap
  • RGEN 8.2B
  • CELH 8.9B
  • IPO Year
  • RGEN N/A
  • CELH N/A
  • Fundamental
  • Price
  • RGEN $147.07
  • CELH $31.96
  • Analyst Decision
  • RGEN Buy
  • CELH Strong Buy
  • Analyst Count
  • RGEN 10
  • CELH 16
  • Target Price
  • RGEN $188.38
  • CELH $58.60
  • AVG Volume (30 Days)
  • RGEN 871.2K
  • CELH 5.6M
  • Earning Date
  • RGEN 10-29-2024
  • CELH 08-06-2024
  • Dividend Yield
  • RGEN N/A
  • CELH N/A
  • EPS Growth
  • RGEN N/A
  • CELH N/A
  • EPS
  • RGEN N/A
  • CELH 1.02
  • Revenue
  • RGEN $602,354,000.00
  • CELH $1,489,877,000.00
  • Revenue This Year
  • RGEN $0.08
  • CELH $17.90
  • Revenue Next Year
  • RGEN $12.97
  • CELH $18.34
  • P/E Ratio
  • RGEN N/A
  • CELH $31.39
  • Revenue Growth
  • RGEN N/A
  • CELH 56.50
  • 52 Week Low
  • RGEN $110.45
  • CELH $31.55
  • 52 Week High
  • RGEN $211.13
  • CELH $99.62
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 48.18
  • CELH 23.24
  • Support Level
  • RGEN $139.41
  • CELH $39.19
  • Resistance Level
  • RGEN $152.92
  • CELH $38.70
  • Average True Range (ATR)
  • RGEN 5.53
  • CELH 1.83
  • MACD
  • RGEN -1.29
  • CELH -0.30
  • Stochastic Oscillator
  • RGEN 43.82
  • CELH 3.99

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About CELH Celsius Holdings Inc.

Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages (including those that are naturally caffeinated with stevia), Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.

Share on Social Networks: